Balyasny Asset Management LLC Nektar Therapeutics Transaction History

Balyasny Asset Management LLC

$54.9 Billion
Q2 2024

A detailed history of Balyasny Asset Management LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Balyasny Asset Management LLC holds 264,063 shares of NKTR stock, worth $308,953. This represents 0.0% of its overall portfolio holdings.

Number of Shares

264,063

Previous 299,633 11.87%

Holding current value

$308,953

Previous $278,000 17.63%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.9 - $1.83 $32,013 - $65,093	-35,570 Reduced 11.87%	264,063 $327,000
Q1 2024 May 13, 2024	SELL	$0.49 - $0.96 $392,179 - $768,352	-800,367 Reduced 72.76%	299,633 $278,000
Q4 2023 Feb 14, 2024	SELL	$0.42 - $0.57 $98,140 - $133,190	-233,668 Reduced 17.52%	1,100,000 $616,000
Q3 2023 Nov 14, 2023	BUY	$0.51 - $1.05 $657,490 - $1.35 Million	1,289,198 Added 2899.03%	1,333,668 $800,000
Q2 2023 Aug 14, 2023	BUY	$0.53 - $1.03 $23,569 - $45,804	44,470 New	44,470 $25,000
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.14 $44,116 - $74,591	14,512 New	14,512 $46,000
Q2 2022 Aug 15, 2022	SELL	$3.17 - $6.17 $2.12 Million - $4.13 Million	-668,827 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $2.66 Million - $8.76 Million	638,347 Added 2094.31%	668,827 $3.61 Million
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $1.55 Million - $2.63 Million	-143,038 Reduced 82.43%	30,480 $412,000
Q3 2021 Nov 15, 2021	BUY	$13.07 - $18.84 $2.27 Million - $3.27 Million	173,518 New	173,518 $3.12 Million
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $1.94 Million - $3.75 Million	-134,277 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$15.87 - $23.12 $2.13 Million - $3.1 Million	134,277 New	134,277 $2.9 Million
Q3 2019 Nov 14, 2019	SELL	$16.91 - $36.27 $2.74 Million - $5.87 Million	-161,829 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$31.0 - $36.3 $359,662 - $421,152	-11,602 Reduced 6.69%	161,829 $5.76 Million
Q1 2019 May 15, 2019	BUY	$31.58 - $46.35 $2.33 Million - $3.41 Million	73,637 Added 73.79%	173,431 $5.83 Million
Q4 2018 Feb 14, 2019	BUY	$30.43 - $56.65 $2.63 Million - $4.89 Million	86,293 Added 639.16%	99,794 $3.28 Million
Q3 2018 Nov 14, 2018	SELL	$46.46 - $68.49 $720,083 - $1.06 Million	-15,499 Reduced 53.44%	13,501 $823,000
Q4 2017 Feb 14, 2018	SELL	$23.02 - $60.5 $17.6 Million - $46.2 Million	-763,782 Reduced 96.34%	29,000 $1.73 Million
Q3 2017 Nov 14, 2017	BUY	$17.79 - $24.0 $14.1 Million - $19 Million	792,782	792,782 $19 Million

Others Institutions Holding NKTR

# of Institutions

140

Shares Held

135M

Call Options Held

32.8K

Put Options Held

55.5K

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Nektar Therapeutics Transaction History